1. Home
  2. SDGR

SDGR

Schrodinger Inc.

Logo Schrodinger Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-22-2024 4:00pm EST

$
-
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.

Founded: 1990 Country:
United States
United States
Employees: N/A City: NEW YORK
Market Cap: 1.8B IPO Year: 2020
Target Price: $41.67 AVG Volume (30 days): 856.3K
Analyst Decision: Buy Number of Analysts: 9
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: 0.54 EPS Growth: N/A
52 Week Low/High: $20.76 - $59.24 Next Earning Date: 05-01-2024
Revenue: $216,666,000 Revenue Growth: 19.73%
Revenue Growth (this year): -2.7% Revenue Growth (next year): 39.79%

Share on Social Networks: